Glucocorticoid therapy in acute liver failure: Survival outcomes, predictors, and a response prediction model

doi:10.4254/wjh.v18.i4.117905

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

(38)

(34)

(0)

(662)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Apr 27, 2026; 18(4): 117905
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.117905

Full Size Figure Download Figure

Figure 2 Corticosteroid use and biochemical changes in patients with acute liver failure. A: Timing and duration of hormone use in patients with acute liver failure; B: Block diagram showing the temporal trends of serum total bilirubin, international normalized ratio, and prothrombin activity response and nonresponse to corticosteroids in patients with acute liver failure over a period of 3 days. TBIL: Total bilirubin; INR: International normalized; PTA: Prothrombin activity.

Citation: He YL, Yin XH, Xu XT, Li J, Meng QH. Glucocorticoid therapy in acute liver failure: Survival outcomes, predictors, and a response prediction model. World J Hepatol 2026; 18(4): 117905
URL: https://www.wjgnet.com/1948-5182/full/v18/i4/117905.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i4.117905

He YL, Yin XH, Xu XT, Li J, Meng QH. Glucocorticoid therapy in acute liver failure: Survival outcomes, predictors, and a response prediction model. World J Hepatol 2026; 18(4): 117905 [DOI: 10.4254/wjh.v18.i4.117905]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.